Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy
Metrics: PDF 1916 views | HTML 1904 views | ?
Jia You1, Yuyuan Chen1, Zubaeda M. Mohamed Alsayeh1, Xingyu Shen1, Chun Li1, Pengxuan Zhao1, Fei Chen2, Yingqian Liu3, Chuanrui Xu1
1School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P. R. China
2Max Planck Institute for Polymer Research, 55128 Mainz, Germany
3School of Pharmacy, Lanzhou University, Lanzhou, 730000, P. R. China
Chuanrui Xu, email: [email protected]
Yingqian Liu, email: [email protected]
Keywords: camptothecin, nanocrystal, WCN-21, bottom-up approach, cancer therapy
Received: November 25, 2016 Accepted: February 23, 2017 Published: March 13, 2017
WCN-21 is a new camptothecin derivative we synthesized and has desirable anti-tumor efficacy, but its aqueous solubility is very low and hurdles the further evaluation and development. In this study, we prepared nanocrystals of WCN-21 through a bottom-up approach to enhance its solubility and obtained WCN-21 nanorods (WND) and nanospheres (WNP). We investigated the crystallization of WND and WNP in different temperature and solvents and found that both temperature and solvents affect the crystal shapes and sizes. We prepared WND at 50°C and DMSO : H2O 1: 50 and WNP at 25°C and DMSO : H2O 1: 100 and found they were dispersed evenly in water with average hydrodynamic diameters 337 and 231 nm, respectively. WND and WNP increased the solubility of WCN-21 from extreme insolubility to more than 9 and 11 mM in H2O or PBS, respectively. In vitro studies showed that WND and WNP enhanced the uptake of WCN-21 in tumor cells by 3 and 9 folds, and increased cytotoxicity of WCN-21 in comparison with free WCN-21 by 5 and 6 folds, respectively. In xenograft tumor mice, intravenous injection of WND and WNP enhanced the accumulation of WCN-21 in tumor tissues and improved the anti-tumor efficacy. In addition, WND and WNP did not increase the toxicity of WCN-21 in mice. Therefore, nanocrystal is a robust tool to improve the solubility of insoluble drugs and holds a great potential in the application of drug development.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.